Int. J. Cancer

Publications

ISSN	1097-0215
ISSN-L	0020-7136
IUID	1cfa24dfe6b64535b3290bdee9e6a8b3
Modified	2020-11-27T13:14:01.262Z
Created	2017-05-09T09:12:10.081Z

Year 2022

PubMed DOI Crossref

Regulatory networks and 5' partner usage of miRNA host gene fusions in breast cancer.

Hafstað V, Søkilde R, Häkkinen J, ..., Rovira C, Persson H

Int. J. Cancer - (-) - [2022-02-19; online 2022-02-19]

Bioinformatics Long-term Support WABI [Collaborative] Bioinformatics Support, Infrastructure and Training [Collaborative]

Year 2021

PubMed DOI Crossref

Genome-wide estrogen receptor β chromatin binding in human colon cancer cells reveals its tumor suppressor activity.

Indukuri R, Jafferali MH, Song D, ..., Archer A, Williams C

Int. J. Cancer 149 (3) 692-706 [2021-08-01; online 2021-04-05]

Bioinformatics Compute and Storage [Service] NGI Stockholm (Genomics Applications) NGI Stockholm (Genomics Production) National Genomics Infrastructure

PubMed DOI Crossref

Association between breast cancer risk and disease aggressiveness: Characterizing underlying gene expression patterns.

Ugalde-Morales E, Grassmann F, Humphreys K, ..., Hall P, Czene K

Int. J. Cancer 148 (4) 884-894 [2021-02-15; online 2020-09-05]

Bioinformatics Support and Infrastructure [Service] Bioinformatics Support, Infrastructure and Training [Service]

Year 2020

PubMed DOI Crossref

Pericyte dysfunction due to Shb gene deficiency increases B16F10 melanoma lung metastasis.

He Q, Li X, He L, ..., Betsholtz C, Welsh M

Int. J. Cancer 147 (9) 2634-2644 [2020-11-01; online 2020-05-30]

Bioinformatics Compute and Storage [Service] NGI Uppsala (SNP&SEQ Technology Platform) [Service] National Genomics Infrastructure [Service]

PubMed DOI Crossref

Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma.

Sjödahl G, Eriksson P, Patschan O, ..., Liedberg F, Höglund M

Int. J. Cancer 146 (9) 2636-2647 [2020-05-01; online 2019-11-14]

Clinical Genomics Lund [Service]

Year 2019

PubMed DOI Crossref

Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia.

Papakonstantinou N, Ntoufa S, Tsagiopoulou M, ..., Rosenquist R, Stamatopoulos K

Int. J. Cancer 144 (11) 2695-2706 [2019-06-01; online 2019-01-15]

NGI Uppsala (SNP&SEQ Technology Platform) [Service] National Genomics Infrastructure [Service]

Year 2018

PubMed DOI Crossref

Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer.

La Fleur L, Boura VF, Alexeyenko A, ..., Karlsson MCI, Botling J

Int. J. Cancer - (-) - [2018-04-18; online 2018-04-18]

Bioinformatics Compute and Storage [Service] Bioinformatics Support and Infrastructure [Service] Bioinformatics Support, Infrastructure and Training [Service] Clinical Genomics Uppsala [Collaborative] NGI Stockholm (Genomics Applications) [Service] NGI Stockholm (Genomics Production) [Service] National Genomics Infrastructure [Service]

Year 2015

PubMed DOI Crossref

A prognosis based classification of undifferentiated uterine sarcomas: identification of mitotic index, hormone receptors and YWHAE-FAM22 translocation status as predictors of survival.

Gremel G, Liew M, Hamzei F, ..., Pontén F, Carlson JW

Int. J. Cancer 136 (7) 1608-1618 [2015-04-01; online 2014-08-19]

Tissue Profiling

Year 2014

PubMed DOI Crossref

Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.

Micke P, Mattsson JS, Edlund K, ..., Sahin U, Türeci O

Int. J. Cancer 135 (9) 2206-2214 [2014-11-01; online 2014-04-09]

Tissue Profiling

PubMed DOI Crossref

Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.

Cajuso T, Hänninen UA, Kondelin J, ..., Kilpivaara O, Vahteristo P

Int. J. Cancer 135 (3) 611-623 [2014-08-01; online 2014-01-03]

Karolinska High Throughput Center (KHTC)

PubMed DOI Crossref

A study of embryonic stem cell-related proteins in human astrocytomas: identification of Nanog as a predictor of survival.

Elsir T, Edqvist PH, Carlson J, ..., Nistér M, Smits A

Int. J. Cancer 134 (5) 1123-1131 [2014-03-01; online 2013-09-17]

Tissue Profiling

Year 2013

PubMed DOI Crossref

Novel signatures of cancer-associated fibroblasts.

Bozóky B, Savchenko A, Csermely P, ..., Székely L, Klein G

Int. J. Cancer 133 (2) 286-293 [2013-07-15; online 2013-01-16]

Tissue Profiling

Year 2012

PubMed DOI Crossref

CD99 is a novel prognostic stromal marker in non-small cell lung cancer.

Edlund K, Lindskog C, Saito A, ..., Ostman A, Micke P

Int. J. Cancer 131 (10) 2264-2273 [2012-11-15; online 2012-03-07]

Array and Analysis Facility Tissue Profiling

PubMed DOI Crossref

Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility.

Castro FA, Ivansson EL, Schmitt M, ..., Gyllensten UB, Pawlita M

Int. J. Cancer 130 (2) 349-355 [2012-01-15; online 2011-03-10]

NGI Uppsala (Uppsala Genome Center) National Genomics Infrastructure